Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale neuroscientists received a $40 million NIH grant to develop brain-delivery technology for gene editing, but the project faces scrutiny due to a lack of published data. Experts emphasize that blood-brain barrier delivery remains a significant hurdle in genetic medicine.
Why it matters
Highlights the tension between high-stakes scientific funding and the need for transparency and peer-reviewed validation.
When Yong-Hui Jiang and Jiangbing Zhou, two Yale University neuroscientists, received a $40 million commitment from the U.S. National Institutes of Health (NIH) in 2023 to develop a technology to deliver gene editors deep into the brain, Yale announced that the technology could “revolutionize genome-editing therapy” and possibly treat up to thousands of genetic diseases of the brain.
Balanced reporting on scientific progress and legitimate academic skepticism.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in